Table II.

Summary of specific ligands characterized from the HLA-B15 allotypes

Allele(s)LigandSource ProteinReferences
B*1508, B*1501, B*1503SQFGGGSQYeIF3-p66 (61–69)a42, 43, this study
B*1508, B*1501, B*1503CPLSCFTHTGS databasebThis study
B*1501, B*1503GQRKGAGSVFRibosomal protein L8 (7–16)42, this study
B*1508, B*1501FVSNHAYAldolase (358–364)This study
B*1508, B*1501VVAPITTGYCalcyclin binding protein (63–71)This study
B*1508, B*1501VGYVDDTQFHLA-I α (25–33)This study
B*1502,c B*1508, B*1501ILGPPGSVYUbiquitin-protein ligase (83–91)36, this study
B*4601,c B*1502,c B*1508,c B*1501YMIDPSGVSYProteasome subunit C8 (150–159)42, 36, this study
B*1501VQGPVGTDFZinc finger transcription factor (296–304)This study
B*1503IKADHVSTYHLA-II DPα (32–40)This study
B*1508LPHQPLATYOct-binding factor 1 (52–60)36, this study
B*1510EHVASSPAL13S Golgi transport complex 90 kDa subunit (741–749)This study
B*1510NHAIVSTSV26S protease (S4) regulatory subunit (119–127)This study
B*1509,c B*1510HHSDGSVSLTapasin (354–362)36, this study
  • a Residues are numbered from the initiating residue of the mature proteins.

  • b Peptide sequence demonstrated homology within the high-throughput genomic sequencing database.

  • c HLA-B15 allotype other than B*1508, B*1501, B*1503, or B*1510 from which the ligand was previously characterized.